Every SEC Form 3/4/5 on record for this filer (CIK 2073519) — 4 issuers, 2 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PMAX | Powell Max Ltd | CEO and Chairman · Director | 2026-05-14 → 2026-05-14 | 1 | — |
| LIXT | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | CEO and Chairman of the Board · Director | 2025-06-18 → 2026-04-17 | 3 | — |
| GRDX | GridAI Technologies Corp. | Director | 2026-01-05 → 2026-01-05 | 1 | — |
| ENTO | Entero Therapeutics, Inc. | Director | 2025-08-18 → 2025-08-18 | 1 | — |
No open-market buy or sale on record — only grants, exercises, withholding or gifts. Switch to “All forms” to see them.
2 of 4 issuers are covered and open a security page; the rest are on file here only.